Staphylococcal immune evasion proteins: Structure, function, and host adaptation

Current Topics in Microbiology and Immunology

Volumn 409, Issue , 2017, Pages 441-489

  Koymans, Kirsten J ^a   Vrieling, Manouk ^a   Gorham, Ronald D ^a   van Strijp, Jos A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHEMOTAXIS INHIBITOR; COAGULASE; COMPLEMENT INHIBITOR; FIBRINOGEN; FORMYLPEPTIDE RECEPTOR; HEMOLYSIN; IMMUNOGLOBULIN BINDING FACTOR; MARAVIROC; NUCLEASE; PROTEINASE; SCLEROPROTEIN; STAPHYLOCOCCUS VACCINE; STAPHYLOKINASE; SUPERANTIGEN; TOXIN;

ADAPTATION; ALPHA HELIX; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; DRUG EFFICACY; GENE CLUSTER; GENETIC VARIABILITY; GENOMIC ISLAND; HOST RANGE; HUMAN; IEC2 GENE; IMMUNE EVASION; NONHUMAN; PRIORITY JOURNAL; PROPHAGE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL;

ANIMALS; HUMANS; IMMUNE EVASION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85041292752     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/82_2015_5017     Document Type: Chapter

References (275)

1. Aarestrup FM, Larsen HD, Eriksen NH et al (1999) Frequency of alpha- and beta-haemolysin in Staphylococcus aureus of bovine and human origin. A comparison between pheno- and genotype and variation in phenotypic expression. APMIS 107:425–430
2. Abdelbary MMH, Wittenberg A, Cuny C et al (2014) Phylogenetic analysis of Staphylococcus aureus CC398 reveals a sub-lineage epidemiologically associated with infections in horses. PLoS ONE 9:e88083
3. Adhikari RP, Ajao AO, Aman MJ et al (2012a) Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis 206:915–923
4. Adhikari RP, Karauzum H, Sarwar J et al (2012b) Novel structurally designed vaccine for s. aureus α-hemolysin: protection against bacteremia and pneumonia. PLoS One 7:e38567
5. Alibayov B, Zdenkova K, Sykorova H, Demnerova K (2014) Molecular analysis of Staphylococcus aureus pathogenicity islands (SaPI) and their superantigens combination of food samples. J Microbiol Methods 107:197–204
6. Allegretti M, Moriconi A, Beccari AR et al (2005) Targeting C5a: recent advances in drug discovery. Curr Med Chem 12:217–236
7. Alonzo F, Torres VJ (2014) The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev 78:199–230
8. Alonzo F, Kozhaya L, Rawlings SA et al (2013) CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493:51–55
9. Anderson MJ, Lin Y-C, Gillman AN et al (2012) Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front Cell Infect Microbiol 2:1–10
10. Arbuthnott J (1970) Staphylococcal alpha toxin. Microbial Toxins 189–236
11. Arcus V (2002) OB-fold domains: a snapshot of the evolution of sequence, structure and function. Curr Opin Struct Biol 12:794–801
12. Armstrong PCJ, Hu H, Rivera J et al (2012) Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complications in vivo: Inhibition by an anti-SSL5 antibody and the glycan Bimosiamose. J Thromb Haemost 10:2607–2609
13. Atkins KL, Burman JD, Chamberlain ES et al (2008) S. aureus IgG-binding proteins SpA and Sbi: Host specificity and mechanisms of immune complex formation. Mol Immunol 45:1600–1611
14. Baba T, Takeuchi F, Kuroda M et al (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819–1827
15. Baba T, Bae T, Schneewind O et al (2008) Genome sequence of Staphylococcus aureus strain newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 190:300–310
16. Badarau A, Rouha H, Malafa S et al (2015) Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi-component toxin LukGH. J Biol Chem 290:142–156
17. Baker HM, Basu I, Chung MC et al (2007) Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J Mol Biol 374:1298–1308
18. Bardoel BW, Vos R, Bouman T et al (2012) Evasion of toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med 90:1109–1120
19. Barretti P, Montelli AC, Batalha JEN et al (2009) The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients. BMC Infect Dis 9:212
20. Barrio M, Rainard P, Prévost G (2006) LukM/LukF′-PV is the most active Staphylococcus aureus leukotoxin on bovine neutrophils. Microbes Infect 8:2068–2074
21. Bassetti M, Nicco E, Mikulska M (2009) Why is community-associated MRSA spreading across the world and how will it change clinical practice? Int J Antimicrob Agents 34:S15–S19
22. Becker K, Friedrich AW, Lubritz G et al (2003) Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 41:1434–1439
23. Becker REN, Berube BJ, Sampedro GR et al (2014a) Tissue-specific patterning of host innate immune responses by Staphylococcus aureus α-toxin. J Innate Immun 6:619–631
24. Becker S, Frankel MB, Schneewind O, Missiakas D (2014b) Release of protein A from the cell wall of Staphylococcus aureus. Proc Natl Acad Sci USA 111:1574–1579
25. Berends ETM, Horswill AR, Haste NM et al (2010) Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J Innate Immun 2:576–586
26. Berends ETM, Kuipers A, Ravesloot MM et al (2014) Bacteria under stress by complement and coagulation. FEMS Microbiol Rev 38:1146–1171
27. Berube BJ, Bubeck Wardenburg JB (2013) Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) 5:1140–1166
28. Bestebroer J, Poppelier MJJG, Ulfman LH et al (2007) Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 109:2936–2943
29. Bestebroer J, Van Kessel KPM, Azouagh H et al (2009) Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood 113:328–337
30. Bestebroer J, Aerts PC, Rooijakkers SHM et al (2010) Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell Microbiol 12:1506–1516
31. Bjerketorp J, Nilsson M, Ljungh A et al (2002) A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology 148:2037–2044
32. Bjerketorp J, Jacobsson K, Frykberg L (2004) The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett 234:309–314
33. Boer JC, Domanska UM, Timmer-Bosscha H et al (2013) Inhibition of formyl peptide receptor in high-grade astrocytoma by chemotaxis inhibitory protein of S. aureus. Br J Cancer 108:587–596
34. Boerhout E, Vrieling M, Benedictus L et al (2015) Immunization routes in cattle impact the levels and neutralizing capacity of antibodies induced against S. aureus immune evasion proteins. Vet Res 46:115
35. Bunschoten A, Ippel JH, Kruijtzer JAW et al (2011) A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds. Amino Acids 40:731–740
36. Buonpane RA, Churchill HRO, Moza B et al (2007) Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 13:725–729
37. Burman JD, Leung E, Atkins KL et al (2008) Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem 283:17579–17593
38. Burroughs M, Balaji S, Iyer LM, Aravind L (2007) Small but versatile: the extraordinary functional and structural diversity of the beta-grasp fold. Biol Direct 2:18
39. Cheng AG, Kim HK, Burts ML et al (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23:3393–3404
40. Cheng AG, McAdow M, Kim HK et al (2010) Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 6:e1001036
41. Cheung GYC, Kretschmer D, Duong AC et al (2014a) Production of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection. PLoS Pathog 10:e1004298
42. Cheung GYC, Kretschmer D, Queck SY et al (2014b) Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) α3 peptide. FASEB J 28:153–161
43. Choi YW, Herman A, DiGiusto D et al (1990) Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 346:471–473
44. Chung MC, Wines BD, Baker H et al (2007) The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol 66:1342–1355
45. Cifrian E, Guidry AJ, Bramley AJ et al (1996) Effect of staphylococcal beta toxin on the cytotoxicity, proliferation and adherence of Staphylococcus aureus to bovine mammary epithelial cells. Vet Microbiol 48:187–198
46. Cinader B, Dubiski S, Wardlaw AC (1964) Distribution, inheritance, and properties of an antigen, MUB1, and its relation to hemolytic complement. J Exp Med 120:897–924
47. Cooney J, Kienle Z, Foster TJ, O’Toole PW (1993) The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infect Immun 61:768–771
48. Cooper LZ, Madoff MA, Weinstein L (1964) Hemolysis of rabbit erythrocytes by purified staphylococcal alpha-toxin. I. Kinetics of the lytic reaction. J Bacteriol 87:127–135
49. Crémieux A-C, Dumitrescu O, Lina G et al (2009) Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS ONE 4:e7204
50. Cuny C, Abdelbary M, Layer F et al (2015) Prevalence of the immune evasion gene cluster in Staphylococcus aureus CC398. Vet Microbiol 177:219–223
51. De Haas CJC, Veldkamp KE, Peschel A et al (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199:687–695
52. De Haas CJC, Weeterings C, Vughs MM et al (2009) Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3. J Thromb Haemost 7:1867–1874
53. Deis LN, Pemble CW, Qi Y et al (2014) Multiscale conformational heterogeneity in staphylococcal protein A: possible determinant of functional plasticity. Structure 22:1467– 1477
54. Deis LN, Wu Q, Wang Y et al (2015) Suppression of conformational heterogeneity at a protein– protein interface. Proc Natl Acad Sci USA 112:9028–9033
55. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375:1557–1568
56. DeLeo FR, Kennedy AD, Chen L et al (2011) Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci USA 108:18091–18096
57. Deringer JR, Ely RJ, Monday SR et al (1997) Vbeta-dependent stimulation of bovine and human T cells by host-specific staphylococcal enterotoxins. Infect Immun 65:4048–4054
58. Diep BA, Palazzolo-Ballance AM, Tattevin P et al (2008) Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 3:e3198
59. Diep BA, Chan L, Tattevin P et al (2010) Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 107:5587–5592
60. Dinges MM, Gregerson DS, Tripp TJ et al (2003) Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. J Infect Dis 188:1142–1145
61. Dumont AL, Nygaard TK, Watkins RL et al (2011) Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 79:814–825
62. DuMont AL, Yoong P, Day CJ et al (2013) Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci USA 110:10794–10799
63. Economou A (2002) Bacterial secretome: the assembly manual and operating instructions (review). Mol Membr Biol 19:159–169
64. Everitt RG, Didelot X, Batty EM et al (2014) Mobile elements drive recombination hotspots in the core genome of Staphylococcus aureus. Nat Commun 5:3956
65. Falugi F, Kim HK, Missiakas DM, Schneewind O (2013) Role of protein a in the evasion of host adaptive immune responses by Staphylococcus aureus. mBio 4:e00575-13
66. Fevre C, Bestebroer J, Mebius MM et al (2014) Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display. Cell Microbiol 16:1646–1665
67. Fitzgerald JR, Monday SR, Foster TJ et al (2001) Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J Bacteriol 183:63–70
68. Fitzgerald JR, Reid SD, Ruotsalainen E et al (2003) Genome diversification in Staphylococcus aureus: molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infect Immun 71:2827–2838
69. Fitzgerald JR (2012) Livestock-associated Staphylococcus aureus: origin, evolution and public health threat. Trends Microbiol 20:192–198
70. Foletti D, Strop P, Shaughnessy L et al (2013) Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. J Mol Biol 425:1641– 1654
71. Fowler VG, Proctor RA (2014) Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect 20:66–75
72. Fraser JD, Proft T (2008) The bacterial superantigen and superantigen-like proteins. Immunol Rev 225:226–243
73. Friedrich R, Panizzi P, Fuentes-Prior P et al (2003) Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 425:535–539
74. Friedrich R, Panizzi P, Kawabata SI et al (2006) Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation. J Biol Chem 281:1188–1195
75. Fritz SA, Tiemann KM, Hogan PG et al (2013) A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin Infect Dis 56:1554–1561
76. Fromageau A, Gilbert FB, Prévost G, Rainard P (2010) Binding of the Staphylococcus aureus leucotoxin LukM to its leucocyte targets. Microb Pathog 49:354–362
77. Galdiero S, Gouaux E (2004) High resolution crystallographic studies of alpha-hemolysinphospholipid complexes define heptamer–lipid head group interactions: Implication for understanding protein–lipid interactions, pp 1503–1511
78. Garcia BL, Ramyar KX, Tzekou A et al (2010) Molecular basis for complement recognition and inhibition determined by crystallographic studies of the Staphylococcal complement inhibitor (SCIN) bound to C3c and C3b. J Mol Biol 402:17–29
79. Garcia BL, Ramyar KX, Ricklin D et al (2012a) Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins. Adv Exp Med Biol 946:113–133
80. Garcia BL, Summers BJ, Lin Z et al (2012b) Diversity in the C3b convertase contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein family. J Biol Chem 287:628–640
81. Garcia BL, Summers BJ, Ramyar KX et al (2013) A structurally dynamic n-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins. J Biol Chem 288:2870–2881
82. Geisbrecht BV, Hamaoka BY, Perman B et al (2005) The crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens. J Biol Chem 280:17243–17250
83. Gill SR, Fouts DE, Archer GL et al (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187:2426–2438
84. Gillet Y, Issartel B, Vanhems P, et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (London, England) 359:753–759
85. Gladysheva IP, Turner RB, Sazonova IY et al (2003) Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci USA 100:9168–9172
86. Gómez MI, Lee A, Reddy B et al (2004) Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 10:842–848
87. Gómez MI, O’Seaghdha M, Magargee M et al (2006) Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem 281:20190–20196
88. Goodyear CS, Silverman GJ (2003) Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J Exp Med 197:1125–1139
89. Graille M, Stura EA, Corper AL et al (2000) Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 97:5399– 5404
90. Grumann D, Nübel U, Bröker BM (2014) Staphylococcus aureus toxins—their functions and genetics. Infect Genet Evol 21:583–592
91. Guillet V, Roblin P, Werner S et al (2004) Crystal structure of leucotoxin S component: New insight into the staphylococcal β-barrel pore-forming toxins. J Biol Chem 279:41028–41037
92. Guinane CM, Sturdevant DE, Herron-Olson L et al (2008) Pathogenomic analysis of the common bovine Staphylococcus aureus clone (ET3): emergence of a virulent subtype with potential risk to public health. J Infect Dis 197:205–213. doi:10.1086/524689
93. Guinane CM, Ben Zakour NL, Tormo-Mas MA et al (2010) Evolutionary genomics of Staphylococcus aureus reveals insights into the origin and molecular basis of ruminant host adaptation. Genome Biol Evol 2:454–466
94. Guinane CM, Penadés JR, Fitzgerald JR (2011) The role of horizontal gene transfer in Staphylococcus aureus host adaptation. Virulence 2:241–243
95. Haas PJ, de Haas CJC, Kleibeuker W et al (2004) N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J Immunol 173:5704–5711
96. Haas PJ, de Haas CJC, Poppelier MJJC et al (2005) The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. J Mol Biol 353:859–872
97. Hammel M, Nemecek D, Keightley JA et al (2007) The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution. Protein Sci 16:2605–2617
98. Hartleib J, Köhler N, Dickinson RB et al (2000) Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 96:2149–2156
99. Haupt K, Reuter M, Van Den Elsen J et al (2008) The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b. PLoS Pathog 4:e10000250
100. Henson SE, Smith D, Boackle SA et al (2001) Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J Immunol Methods 258:97–109
101. Hermans SJ, Baker HM, Sequeira RP et al (2012) Structural and functional properties of staphylococcal superantigen-like protein 4. Infect Immun 80:4004–4013
102. Herron-Olson L, Fitzgerald JR, Musser JM, Kapur V (2007) Molecular correlates of host specialization in Staphylococcus aureus. PLoS ONE 2:e1120
103. Hidron AI, Low CE, Honig EG, Blumberg HM (2009) Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 9:384–392
104. Holt DC, Holden MTG, Tong SYC et al (2011) A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol 3:881–895
105. Holtfreter S, Bauer K, Thomas D et al (2004) egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun 72:4061–4071
106. Hu H, Armstrong PCJ, Khalil E et al (2011) GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS ONE 6:e19190
107. Huseby M, Shi K, Kent Brown C et al (2007) Structure and biological activities of beta toxin from Staphylococcus aureus. J Bacteriol 189:8719–8726
108. Hussain M, Haggar A, Peters G et al (2008) More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. Infect Immun 76:5615–5623
109. Inoshima I, Inoshima N, Wilke GA et al (2011) A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 17:1310–1314
110. Inoshima N, Wang Y, Wardenburg JB (2012) Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J Invest Dermatol 132:1513–1516
111. Ippel JH, de Haas CJC, Bunschoten A et al (2009) Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus. J Biol Chem 284:12363–12372
112. Itoh S, Hamada E, Kamoshida G et al (2010a) Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils. Infect Immun 78:3298–3305
113. Itoh S, Hamada E, Kamoshida G et al (2010b) Staphylococcal superantigen-like protein 10 (SSL10) binds to human immunoglobulin G (IgG) and inhibits complement activation via the classical pathway. Mol Immunol 47:932–938
114. Itoh S, Yamaoka N, Kamoshida G et al (2013a) Staphylococcal superantigen-like protein 8 (SSL8) binds to tenascin C and inhibits tenascin C-fibronectin interaction and cell motility of keratinocytes. Biochem Biophys Res Commun 433:127–132
115. Itoh S, Yokoyama R, Kamoshida G et al (2013b) Staphylococcal superantigen-like protein 10 (SSL10) inhibits blood coagulation by binding to prothrombin and factor Xa via their γ-carboxyglutamic acid (Gla) domain. J Biol Chem 288:21569–21580
116. Jarraud S, Peyrat MA, Lim A et al (2001) egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 166:669–677
117. Jin T, Bokarewa M, Foster T et al (2004) Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172:1169–1176
118. Jongerius I, Köhl J, Pandey MK et al (2007) Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 204:2461–2471
119. Jongerius I, Puister M, Wu J et al (2010) Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases. J Immunol 184:420–425
120. Jongerius I, von Köckritz-Blickwede M, Horsburgh MJ et al (2012) Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses. J Innate Immun 4:301–311
121. Jusko M, Potempa J, Kantyka T et al (2014) Staphylococcal proteases aid in evasion of the human complement system. J Innate Immun 6:31–46
122. Kim HK, Kim HY, Schneewind O, Missiakas D (2011) Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses. FASEB J 25:3605–3612
123. Kim HK, Falugi F, Thomer L, Missiakas DM (2015) Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs. mBio 6:1–11
124. Ko YP, Liang X, Smith CW et al (2011) Binding of Efb from Staphylococcus aureus to fibrinogen blocks neutrophil adherence. J Biol Chem 286:9865–9874
125. Ko YP, Kuipers A, Freitag CM et al (2013) Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface. PLoS Pathog 9:1–13
126. Kobayashi SD, Malachowa N, Whitney AR et al (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204:937– 941
127. Koymans KJ, Feitsma LJ, Brondijk THC et al (2015) Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3). Proc Natl Acad Sci USA 112:11018–11023
128. Kretschmer D, Gleske AK, Rautenberg M et al (2010) Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7:463–473
129. Kuehnert MJ, Kruszon-Moran D, Hill HA et al (2006) Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001–2002. J Infect Dis 193:172–179
130. Kumagai R, Nakatani K, Ikeya N et al (2007) Quadruple or quintuple conversion of hlb, sak, sea (or sep), scn, and chp genes by bacteriophages in non-beta-hemolysin-producing bovine isolates of Staphylococcus aureus. Vet Microbiol 122:190–195
131. Kuroda M, Yamashita A, Hirakawa H et al (2005) Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proc Natl Acad Sci USA 102:13272–13277
132. Laarman AJ, Ruyken M, Malone CL et al (2011) Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 186:6445–6453
133. Laarman AJ, Mijnheer G, Mootz JM et al (2012) Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO J 31:3607–3619
134. Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6:132–142
135. Langley R, Wines B, Willoughby N et al (2005) The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol 174:2926–2933
136. Langley R, Patel D, Jackson N et al (2010) Staphylococcal superantigen super-domains in immune evasion. Crit Rev Immunol 30:149–165
137. Langley R, Fraser JD (2013) The staphylococcal Superantigen-like toxins. Bact Toxins: Genet Cell Biol Pract Appl 129–156
138. Laursen NS, Gordon N, Hermans S et al (2010) Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus. Proc Natl Acad Sci USA 107:3681–3686
139. Le KY, Dastgheyb S, Ho TV, Otto M (2014) Molecular determinants of staphylococcal biofilm dispersal and structuring. Front Cell Infect Microbiol 4:1–7
140. Lee PK, Kreiswirth BN, Deringer JR et al (1992) Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J Infect Dis 165:1056–1063
141. Lee SS, Kim YJ, Chung DR et al (2010) Invasive infection caused by a community-associated methicillin-resistant Staphylococcus aureus strain not carrying Panton-Valentine leukocidin in South Korea. J Clin Microbiol 48:311–313
142. Lina G, Piémont Y, Godail-Gamot F et al (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128–1132
143. Lina G, Bohach GA, Nair SP et al (2004) Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 189:2334–2336
144. Lindsay JA, Ruzin A, Ross HF et al (1998) The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol 29:527–543
145. Lindsay JA, Holden MTG (2006a) Understanding the rise of the superbug: Investigation of the evolution and genomic variation of Staphylococcus aureus. Funct Integr Genomics 6:186–201
146. Lindsay JA, Moore CE, Day NP et al (2006b) Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol 188:669–676
147. Lindsay JA (2010) Genomic variation and evolution of Staphylococcus aureus. Int J Med Microbiol 300:98–103
148. Lindsay JA (2014) Staphylococcus aureus genomics and the impact of horizontal gene transfer. Int J Med Microbiol 304:103–109
149. Lipinska U, Hermans K, Meulemans L et al (2011) Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 6:e22864
150. Liu ZJ, Yang YJ, Jiang L et al (2011) Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus. Acta Pharmacol Sin 32:1038–1044
151. Liu Y, Yin H, Zhao M, Lu Q (2013) TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 1–12
152. Löffler B, Hussain M, Grundmeier M et al (2010) Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715
153. Lowder BV, Guinane CM, Ben Zakour NL et al (2009) Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proc Natl Acad Sci USA 106:19545–19550
154. Lowy F (1998) Staphylococcus aureus infections. N Engl J Med 339:520–532
155. Malachowa N, Deleo FR (2010) Mobile genetic elements of Staphylococcus aureus. Cell Mol Life Sci 67:3057–3071
156. Malachowa N, Kobayashi SD, Braughton KR et al (2012) Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis 206:1185–1193
157. Malito E, Carfi A, Bottomley M (2015) Protein crystallography in vaccine research and development. Int J Mol Sci 16:13106–13140
158. McCarthy AJ, Lindsay JA (2010) Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiol 10:173
159. McCarthy AJ, Lindsay JA, Loeffler A (2012a) Are all meticillin-resistant Staphylococcus aureus (MRSA) equal in all hosts? Epidemiological and genetic comparison between animal and human MRSA. Vet Dermatol 23:267–275
160. McCarthy AJ, van Wamel WJB, Vandendriessche S et al (2012b) Staphylococcus aureus CC398 clade associated with human-to-human transmission. Appl Environ Microbiol 78:8845–8848
161. McCarthy AJ, Witney AA, Lindsay JA (2012c) Staphylococcus aureus temperate bacteriophage: carriage and horizontal gene transfer is lineage associated. Front Cell Infect Microbiol 2:6
162. McCarthy AJ, Lindsay JA (2013) Staphylococcus aureus innate immune evasion is lineage-specific: a bioinfomatics study. Infect Genet Evol 19:7–14
163. Monecke S, Kuhnert P, Hotzel H et al (2007) Microarray based study on virulence-associated genes and resistance determinants of Staphylococcus aureus isolates from cattle. Vet Microbiol 125:128–140
164. Monecke S, Luedicke C, Slickers P, Ehricht R (2009) Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 28:1159–1165
165. Moon BY, Park JY, Hwang SY et al (2015) Phage-mediated horizontal transfer of a Staphylococcus aureus virulence-associated genomic island. Sci Rep 5:9784
166. Morinaga N, Kaihou Y, Noda M (2003) Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol 47:81–90
167. Murzin AG (1993) OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences. EMBO J 12:861–867
168. Nakamura Y, Oscherwitz J, Cease KB et al (2013) Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature 503:397–401
169. Nguyen T, Ghebrehiwet B, Ellinor IB (2000) Staphylococcus aureus Protein A recognizes platelet gC1qR/ p33: a novel mechanism for staphylococcal interactions with platelets. Infect Immun 68:2061–2068
170. Novick RP, Subedi A (2007) The SaPIs: mobile pathogenicity islands of Staphylococcus. Chem Immunol Allergy 93:42–57
171. Novick RP, Christie GE, Penadés JR (2010) The phage-related chromosomal islands of Gram-positive bacteria. Nat Rev Microbiol 8:541–551
172. Nygaard TK, Pallister KB, DuMont AL et al (2012) Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS ONE 7:e36532
173. Okumura CYM, Nizet V (2014) Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens. Annu Rev Microbiol 68:439–458
174. Olson R, Nariya H, Yokota K et al (1999) Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat Struct Biol 6:134–140
175. Omoe K, Hu DL, Takahashi-Omoe H et al (2005) Comprehensive analysis of classical and newly described staphylococcal superantigenic toxin genes in Staphylococcus aureus isolates. FEMS Microbiol Lett 246:191–198
176. Ono HK, Sato’o Y, Narita K et al (2015) Identification and characterization of a novel staphylococcal emetic toxin. Appl Environ Microbiol 81:7034–7040
177. Otter JA, French GL (2008) The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006. Clin Microbiol Infect 14:670–676
178. Padmaja RJ, Halami PM (2013) Molecular characterization and toxicity confirmation of LukM/F’-PV producing Staphylococcus aureus isolated from bovine mastitis samples in Mysore, India. Indian J Microbiol 53:276–282
179. Palma M, Shannon O, Quezada HC et al (2001) Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain. J Biol Chem 276:31691–31697
180. Panizzi P, Friedrich R, Fuentes-Prior P et al (2006) Fibrinogen substrate recognition by staphylocoagulase·(Pro)thrombin complexes. J Biol Chem 281:1179–1187
181. Parry MA, Fernandez-Catalan C, Bergner A et al (1998) The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol 5:917–923
182. Patel D, Wines BD, Langley RJ, Fraser JD (2010) Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain. J Immunol 184:6283–6292
183. Pédelacq JD, Maveyraud L, Prévost G et al (1999) The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure 7:277–287
184. Penadés JR, Fitzgerald JR (2009) Toxins encoded by mobile genetic elements. Current research and future trends, Microbial toxins, pp 1–13
185. Peton V, Le Loir Y (2014) Staphylococcus aureus in veterinary medicine. Infect Genet Evol 21:602–615
186. Phimister GM, Freer JH (1984) Binding of 125I-alpha toxin of Staphylococcus aureus to erythrocytes. J Med Microbiol 18:197–204
187. Postma B, Poppelier MJ, van Galen JC et al (2004) Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J Immunol 172:6994–7001
188. Postma B, Kleibeuker W, Poppelier MJJG et al (2005) Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. J Biol Chem 280:2020–2027
189. Powers ME, Kim HK, Wang Y, Wardenburg JB (2012) ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J Infect Dis 206:352–356
190. Prat C, Bestebroer J, de Haas CJC et al (2006) A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J Immunol 177:8017–8026
191. Prat C, Haas PJ, Bestebroer J et al (2009) A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J Immunol 183:6569–6578
192. Price LB, Stegger M, Hasman H, et al (2012) Adaptation and emergence of Staphylococcus aureus CC39: Host adaptation and emergence of methicillin resistance in livestock. mBio 3:e00305-11
193. Prokesová L, Potuzníkovà B, Potempa J et al (1995) Cleavage of human immunoglobulins by proteinase from Staphylococcus aureus. Adv Exp Med Biol 371A:613–616
194. Quiles-Puchalt N, Carpena N, Alonso JC et al (2014) Staphylococcal pathogenicity island DNA packaging system involving cos-site packaging and phage-encoded HNH endonucleases. Proc Natl Acad Sci USA 111:6016–6021
195. Rabijns A, De Bondt H, De Ranter C (1997) Three-dimensional structure of staphylokinase, a plasminogen activator with therapeutic potential. Nat Struct Biol 4:357–360
196. Rahimpour R, Mitchell G, Khandaker MH et al (1999) Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism. J Immunol 162:2299–2307
197. Rainard P, Corrales JC, Barrio MB et al (2003) Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats with mastitis: importance of LukM/LukF’-PV leukotoxin. Clin Diagn Lab Immunol 10:272–277
198. Ramsland PA, Willoughby N, Trist HM et al (2007) Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc Natl Acad Sci USA 104:15051–15056
199. Reyes-Robles T, Alonzo F, Kozhaya L et al (2013) Staphylococcus aureus Leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to Kill leukocytes and promote infection. Cell Host Microbe 14:453–459
200. Ricklin D, Ricklin-Lichtsteiner SK, Markiewski MM et al (2008) Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J Immunol 181:7463–7467
201. Ricklin D, Tzekou A, Garcia BL et al (2009) A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family. J Immunol 183:2565–2574
202. Ricklin D, Lambris JD (2013) Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol 190:3831–3838
203. Rödström KEJ, Elbing K, Lindkvist-Petersson K (2014) Structure of the superantigen staphylococcal enterotoxin B in complex with TCR and peptide-MHC demonstrates absence of TCR-peptide contacts. J Immunol 193:1998–2004
204. Rooijakkers SHM, Ruyken M, Roos A et al (2005a) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6:920–927
205. Rooijakkers SHM, van Wamel WJB, Ruyken M et al (2005b) Anti-opsonic properties of staphylokinase. Microbes Infect 7:476–484
206. Rooijakkers SHM, Milder FJ, Bardoel BW et al (2007) Staphylococcal complement inhibitor: structure and active sites. J Immunol 179:2989–2998
207. Rooijakkers SHM, Wu J, Ruyken M et al (2009) Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat Immunol 10:721–727
208. Rouha H, Badarau A, Visram ZC et al (2015) Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs 7:243–254
209. Salgado-Pabón W, Breshears L, Spaulding AR, et al (2013) Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. mBio 4: e00494-13
210. Salgado-Pabón W, Schlievert PM (2014) Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol 12:585–591
211. Schad EM, Zaitseva I, Zaitsev VN et al (1995) Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J 14:3292–3301
212. Scherr TD, Hanke ML, Huang O et al (2015) Staphylococcus aureus biofilms induce macrophage dysfunction through leukocidin AB and alpha-toxin. mBio 6:e01021-15
213. Schijffelen MJ, Boel CHE, van Strijp JAG, Fluit AC (2010) Whole genome analysis of a livestock-associated methicillin-resistant Staphylococcus aureus ST398 isolate from a case of human endocarditis. BMC Genom 11:376
214. Schlievert PM (2009) Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. J Infect Dis 200:676–678
215. Schlotter K, Ehricht R, Hotzel H et al (2012) Leukocidin genes lukF-P83 and lukM are associated with taphylococcus aureus clonal complexes 151, 479 and 133 isolated from bovine udder infections in Thuringia, Germany. Vet Res 43:42
216. Schneewind O, Model P, Fischetti VA (1992) Sorting of Protein-A to the staphylococcal cell-wall. Cell 70:267–281
217. Schreiner J, Kretschmer D, Klenk J et al (2013) Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol 190:3417–3426
218. Scully IL, Liberator PA, Jansen KU, Anderson AS (2014) Covering all the bases: preclinical development of an effective Staphylococcus aureus vaccine. Front Immunol 5:1–7
219. Sieprawska-lupa M, Mydel P, Wójcik K et al (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673–4679
220. Simpson VR, Davison NJ, Kearns AM et al (2013) Association of a lukM-positive clone of Staphylococcus aureus with fatal exudative dermatitis in red squirrels (Sciurus vulgaris). Vet Microbiol 162:987–991
221. Smagur J, Guzik K, Bzowska M et al (2009) Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages. Biol Chem 390:361–371
222. Smith EJ, Visai L, Kerrigan SW et al (2011) The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun 79:3801–3809
223. Smyth DS, Hartigan PJ, Meaney WJ et al (2005) Superantigen genes encoded by the egc cluster and SaPlbov are predominant among Staphylococcus aureus isolates from cows, goats, sheep, rabbits and poultry. J Med Microbiol 54:401–411
224. Song L, Hobaugh MR, Shustak C et al (1996) Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274:1859–1866
225. Spaan AN, Henry T, Van Rooijen WJM et al (2013) The staphylococcal toxin panton-valentine leukocidin targets human C5a receptors. Cell Host Microbe 13:584–594
226. Spaan AN, Vrieling M, Wallet P et al (2014) The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat Commun 5:5438
227. Spaan AN, Reyes-Robles T, Badiou C et al (2015a) Staphylococcus aureus targets the duffy antigen receptor for chemokines (DARC) to lyse erythrocytes. Cell Host Microbe 18:363–370
228. Spaan AN, Schiepers A, de Haas CJC et al (2015b) Differential interaction of the staphylococcal toxins Panton-Valentine leukocidin and γ-hemolysin CB with human C5a receptors. J Immunol 195:1034–1043
229. Spaulding AR, Salgado-Pabón W, Kohler PL et al (2013) Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26:422–447
230. Stapels DAC, Ramyar KX, Bischoff M et al (2014) Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors that promotes bacterial infection. Proc Natl Acad Sci USA 111:13187–13192
231. Stapels DAC, Kuipers A, von Köckritz-Blickwede M et al (2015) Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases. Cell Microbiol
232. Stemerding AM, Köhl J, Pandey MK et al (2013) Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. J Immunol 191:353–362
233. Stulik L, Malafa S, Hudcova J et al (2014) α-hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia. Am J Respir Crit Care Med 190:1139–1148
234. Stutz K, Stephan R, Tasara T (2011) SpA, ClfA, and FnbA genetic variations lead to Staphaurex test-negative phenotypes in bovine mastitis Staphylococcus aureus isolates. J Clin Microbiol 49:638–646
235. Subedi A, Ubeda C, Adhikari RP et al (2007) Sequence analysis reveals genetic exchanges and intraspecific spread of SaPl2, pathogenicity island involved in menstrual toxic shock. Microbiology 153:3235–3245
236. Summers BJ, Garcia BL, Woehl JL et al (2015) Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins. Mol Immunol 67:193–205
237. Sundberg EJ, Deng L, Mariuzza RA (2007) TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol 19:262–271
238. Sung JML, Lloyd DH, Lindsay JA (2008) Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology 154:1949–1959
239. Surewaard BGJ, Nijland R, Spaan AN et al (2012) Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog 8:e1002606
240. Surewaard BGJ, De Haas CJC, Vervoort F et al (2013) Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell Microbiol 15:1427–1437
241. Takeuchi F, Watanabe S, Baba T et al (2005) Whole-genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J Bacteriol 187:7292–7308
242. Tanaka Y, Hirano N, Kaneko J et al (2011) 2-Methyl-2,4-pentanediol induces spontaneous assembly of staphylococcal α-hemolysin into heptameric pore structure. Protein Sci 20:448–456
243. Thammavongsa V, Missiakas D, Schneewind O (2013) Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death. Science (80-) 342:863–866
244. Thomas DY, Jarraud S, Lemercier B et al (2006) Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster. Infect Immun 74:4724–4734
245. Thomer L, Schneewind O, Missiakas D (2013) Multiple ligands of von willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. J Biol Chem 288:28283–28292
246. Thurlow LR, Hanke ML, Fritz T et al (2011) Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol 186:6585–6596
247. Tollersrud T, Kampen AH, Kenny K (2006) Staphylococcus aureus enterotoxin D is secreted in milk and stimulates specific antibody responses in cows in the course of experimental intramammary infection. Infect Immun 74:3507–3512
248. Tuchscherr L, Heitmann V, Hussain M et al (2010) Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 202:1031–1040
249. van Wamel WJB, Rooijakkers SHM, Ruyken M et al (2006) The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 188:1310–1315
250. Vandenesch F, Naimi T, Enright MC et al (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984
251. Verkaik NJ, Benard M, Boelens HA et al (2011) Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization. Clin Microbiol Infect 17:343–348
252. Viana D, Blanco J, Tormo-Más MÁ et al (2010) Adaptation of Staphylococcus aureus to ruminant and equine hosts involves SaPI-carried variants of von Willebrand factor-binding protein. Mol Microbiol 77:1583–1594
253. Viana D, Comos M, McAdam PR et al (2015) A single natural nucleotide mutation alters bacterial pathogen host tropism. Nat Genet 47:361–366
254. Vrieling M, Koymans KJ, Heesterbeek DAC et al (2015) Bovine Staphylococcus aureus secretes the leukocidin LukMF’ to kill migrating neutrophils through CCR1. mBio 6:e00335
255. Walenkamp AME, Boer IGJ, Bestebroer J et al (2009) Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration. Neoplasia 11:333–344
256. Walenkamp AME, Bestebroer J, Boer IGJ et al (2010) Staphylococcal SSL5 binding to human leukemia cells inhibits cell adhesion to endothelial cells and platelets. Cell Oncol 32:1–10
257. Wang R, Braughton KR, Kretschmer D et al (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510–1514
258. Ward MJ, Gibbons CL, McAdam PR et al (2014) Time-scaled evolutionary analysis of the transmission and antibiotic resistance dynamics of Staphylococcus aureus clonal complex 398. Appl Environ Microbiol 80:7275–7282
259. Watson E, Matousek WM, Irimies EL, Alexandrescu AT (2007) Partially folded states of staphylococcal nuclease highlight the conserved structural hierarchy of OB-fold proteins. Biochemistry 46:9484–9494
260. Wilke G, Bubeck Wardenburg J (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 107:13473–13478
261. Williams RJ, Ward JM, Henderson B et al (2000) Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun 68:4407–4415
262. Willingham SB, Volkmer JP, Gentles AJ et al (2012) The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA 109:6662–6667
263. Wilson GJ, Seo KS, Cartwright RA et al (2011) A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog 7:e1002271
264. Woehl JL, Stapels DAC, Garcia BL et al (2014) The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase. J Immunol 193:6161–6171
265. Xu SX, Gilmore KJ, Szabo PA et al (2014) Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect Immun 82:3588–3598
266. Xu SX, Kasper KJ, Zeppa JJ, McCormick JK (2015) Superantigens modulate bacterial density during Staphylococcus aureus nasal colonization. Toxins (Basel) 7:1821–1836
267. Yamada T, Tochimaru N, Nakasuji S et al (2005) Leukotoxin family genes in Staphylococcus aureus isolated from domestic animals and prevalence of lukM-lukF-PV genes by bacteriophages in bovine isolates. Vet Microbiol 110:97–103
268. Yamashita K, Kawai Y, Tanaka Y et al (2011) Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components. Proc Natl Acad Sci USA 108:17314–17319
269. Yamashita D, Sugawara T, Takeshita M et al (2014) Molecular basis of transmembrane beta-barrel formation of staphylococcal pore-forming toxins. Nat Commun 5:4897
270. Yeung RS, Penninger JM, Kündig T et al (1996) Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur J Immunol 26:1074–1082
271. Yokomizo Y, Mori Y, Shimoji Y et al (1995) Proliferative response and cytokine production of bovine peripheral blood mononuclear cells induced by the superantigens staphylococcal enterotoxins and toxic shock syndrome toxin-1. J Vet Med Sci 57:299–305
272. Yokoyama R, Itoh S, Kamoshida G et al (2012) Staphylococcal superantigen-like protein 3 binds to the toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infect Immun 80:2816–2825
273. Zhang L, Jacobson K, Vasi J et al (1995) A second IgG-binding protein in Staphylococcus aureus. Microbiology 408:985–991
274. Zhang L, Jacobsson K, Ström K et al (1999) Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I. Microbiology 145:177–183
275. Zou D, Kaneko J, Narita S, Kamio Y (2000) Prophage, phiPV83-pro, carrying panton-valentine leukocidin genes, on the Staphylococcus aureus P83 chromosome: comparative analysis of the genome structures of phiPV83-pro, phiPVL, phi11, and other phages. Biosci Biotechnol Biochem 64:2631–2643